期刊文献+

GP73和AFP诊断HBSAg阳性原发性肝癌评价 被引量:4

Determination of Golgi protein 73 and Alpha-fetoprotein in the diagnosis of HBsAg^+ hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨血清高尔基体蛋白73(GP73)和甲胎蛋白(AFP)检测在HBSAg阳性原发性肝癌诊断中的价值。方法对30例健康体检者,32例慢性乙型病毒性肝炎、36例乙肝肝硬化及57例原发性肝癌(HBSAg阳性)患者分别采用酶联免疫吸附试验和微粒子酶免疫分析技术检测血清GP73和AFP含量,并对检测结果进行统计学分析。结果原发性肝癌(HBSAg阳性)患者血清GP73和AFP水平均显著高于其他疾病组及正常对照组(均<0.05)。GP73和AFP诊断HCC的ROC曲线下面积(AUC)为0.862和0.729,95%置信区间为0.796~0.913和0.650~0.799。GP73的最佳诊断界限值为145 ng/ml,其预测的灵敏度为70.18%,特异度为93.33%。GP73的AUC大于AFP的AUC,两者AUC的差异有统计学意义(<0.01)。结论血清GP73对HBSAg阳性原发性肝癌的诊断价值可能优于AFP,可作为一项较好的诊断HCC的血清标志物。 Objective To explore the clinical diagnostic value of Golgi protein 73(GP73) and alpha-fetoprotein(AFP) for hepatocellular carcinoma(HCC) patients with HBsAg+.MethodsTThe serum GP73 and AFP were detected by enzyme-linked immunosorbent assay and microparticle chemiluminescent immunoassay in 32 patients infected with Hepatitis B virus hepatitis,36 cases of cirrhosis,57 cases of hepatocellular carcinoma)and 30 healthy controls.Then a statistical analysis was made on these results.ResultsTIn the patients with HCC(HBsAg+),the serum levels of GP73 and AFP were significantly higher than those in other patients and normal controls(all P0.05),and the area under curve(AUC) generated by the ROC curves was 0.862(95%CI: 0.796~0.913) for GP73 and 0.729(95%CI: 0.650~0.799) for AFP.The best diagnostic threshold of GP73 was 145 ng/ml,and its sensitivity and specificity were 70.18% and 93.33%.The AUC of GP73 was bigger than that of AFP,and the difference was statistically significant(P0.01).ConclusionsThe clinical diagnosis value of GP73 may be better than that of AFP,and GP73 could be a good serum marker in the diagnosis of hepatocellular carcinoma.
出处 《现代实用医学》 2012年第3期261-263,共3页 Modern Practical Medicine
基金 浙江省卫生厅一般研究计划(2011KYB107) 吴阶平医学基金会肝病实验诊断研究基金(LDWMF-SY-2011C004) 宁波市医学科技计划项目(2010A02)
关键词 肝炎病毒 乙型 肝肿瘤 甲胎蛋白 高尔基体蛋白73 Hepatitis B virus Hepatic neoplasm Alpha-fetoprotein Golgi protein 73
  • 相关文献

参考文献10

  • 1Cabibbo G, Craxi A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci, 2010,14(4):352-355.
  • 2Marrem JA, Romano PR, Nikoheva 0, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma[J].J Hepatol,2005,43(6):1007-1012.
  • 3Giannelli G, Antonaci S. New frontiers in biomarkers for hepatoc ellular carcinoma[J]. Dig Liver Dis,2006,38(11):854-859.
  • 4毛一雷,杨华瑜,徐海峰,桑新亭,卢欣,杨志英,张锦春,钟守先,黄洁夫,张宏冰.新的肝癌血清标记物GP73在肝癌诊断中的初步研究[J].中华医学杂志,2008,88(14):948-951. 被引量:132
  • 5Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 6杨秉辉,任正刚.原发性肝癌诊断标准[J].中华肝脏病杂志,2000,8(3):135-135. 被引量:616
  • 7赵发林,侯艳,李康.临床试验评价的ROC分析方法[J].中国卫生统计,2007,24(4):349-351. 被引量:13
  • 8Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection[J].Gene,2000,249 (1-2):53-65.
  • 9Kladney RD, Cui X, Bulla GA, eta 1. Expression of GP73, aresident Go lgil membrane protein, in viral and nonviral liver dis ease [ J]. Hepatology,2002,35(6): 1431-1440.
  • 10Schwegler EE, Cazares L, Steel LF, et al. SELDI-TOF MS Profiling of serum for detection of the Progression of chronic hepatitis C to hepatocellular carcinoma[J]. Hepatology,2005,41 (3):634-642.

二级参考文献24

共引文献2669

同被引文献58

  • 1赛文莉,姚登福,吴玮,邱历伟,杨君伶,张海健,蔚丹丹,秦呈林.外周血高尔基体糖蛋白-73表达水平对肝细胞癌的诊断与鉴别诊断价值[J].中华临床医师杂志(电子版),2011,5(24):7382-7385. 被引量:4
  • 2卢峰,张成军,赵庆书,周华真,钟立国,李增华.原发性肝癌介入治疗进展[J].中国煤炭工业医学杂志,2005,8(2):102-103. 被引量:8
  • 3周晓华.诊断医学统计学[M].宋清华,译.北京:人民卫生出版社,2005:139.
  • 4Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005[J]. J Clin Oncol, 2009, 27(9): 1485- 1491.
  • 5Vanhooren V, Liu XE, Franceschi C, et al. Nglycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing[J]. Mech Ageing Dev, 2009, 130( 1/2):92-97.
  • 6Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgilocalized protein upregulated by viral infection[J]. Gene, 2000, 249(1/2): 53-65.
  • 7Mao Y, Yang H, Xu H, et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma [J]. Gut, 2010, 59(12): 1687-1693.
  • 8Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatoceUular carcinoma[J].J Hepatol, 2005, 43(6): 1007-1012.
  • 9Mao Y, Yang H, Xu H, et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma[J]. Gut, 2010, 59(12):1687-1693.
  • 10Hu JS, Wu DW, Liang S, et al. GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population[J]. Med Oncol, 2009, 27(2): 339-345.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部